サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1572018

経皮的腎結石除去術の世界市場

Percutaneous Nephrolithotomy

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
経皮的腎結石除去術の世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

経皮的腎結石除去術の世界市場は2030年までに4億4,520万米ドルに達する見込み

2023年に3億2,840万米ドルと推定される経皮的腎結石除去術の世界市場は、2030年には4億4,520万米ドルに達し、分析期間2023-2030年のCAGRは4.4%で成長すると予測されます。

米国市場は8,770万米ドルと推定、中国はCAGR 6.6％で成長予測

米国の経皮的腎結石除去術市場は、2023年に8,770万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR 6.6%を牽引し、2030年には予測市場規模9,360万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5%と4.2%と予測されています。欧州では、ドイツがCAGR 2.7%で成長すると予測されています。

世界の経皮的腎結石除去術市場- 主な動向と促進要因

経皮的腎結石除去術とは何か、なぜ大きな腎結石の治療に選ばれているのか？

経皮的腎結石除去術（PCNL）は、体外衝撃波結石破砕術（ESWL）や尿管鏡検査などの低侵襲技術では効果的な治療ができない大きな腎結石や複雑な腎結石を除去するために使用される低侵襲の外科手術です。しかし、PCNLはどのような特徴があり、なぜ大きな腎結石に対して選択されるのでしょうか。この手術では、患者さんの背中を通常1cm未満の小さな切開で切り、そこから腎臓に直接、腎臓鏡（特殊な手術器具）を挿入します。これにより、外科医は結石を可視化し、器具を使って結石を細かく砕いて取り除くことができます。処置後の適切な排液と治癒を確実にするため、多くの場合、一時的にチューブが留置されます。PCNLは、直径2cm以上の結石や棘状結石、腎臓内の解剖学的に難しい場所に結石がある場合に特に有効です。この手技は非常に効率的で、ほとんどの症例で結石除去率は90％を超え、一度の治療で大きな結石や複数の結石を治療するのに適した選択肢となっています。開腹手術と比較して、PCNLは術後の疼痛が少なく、入院期間が短く、回復が早いという利点があり、複雑な腎結石に対する決定的な解決策を必要とする患者に大きなメリットをもたらしています。

最近の技術進歩は、PCNLの安全性と有効性をどのように高めたか？

経皮的腎結石除去術の分野は、手技の安全性プロファイル、精度、結果を大幅に改善した技術の進歩から多大な恩恵を受けています。最も注目すべき進歩の一つは、手術器具の小型化であり、ミニPCNLやウルトラミニPCNLと呼ばれる、さらに小型の腎臓鏡やアクセス管を使用した手術が行われるようになった。この手技は出血のリスクを減らし、腎臓への外傷を最小限に抑えるため、小児患者にも成人にも適しています。もう1つの重要な技術革新は、透視、超音波、リアルタイムCTガイダンスなどの高度な画像モダリティの使用で、解剖学的に複雑な症例であっても、より正確な結石ターゲティングとより安全な腎臓へのアクセスを可能にしています。さらに、レーザーや空気圧式装置を含む新しい結石破砕装置は、硬い結石を破砕する力が強化されており、再手術の必要性が減少しています。これらのエネルギー源は効率を向上させ、外科医は健康な組織を温存しながら、より大きな結石をより迅速に砕くことができるようになった。PCNLにおけるロボット工学とコンピュータ支援ナビゲーションの統合も視野に入っており、精度をさらに高め、泌尿器科医の学習曲線を短縮することが期待されています。さらに、シングルステップ拡張技術とバルーン拡張器により、腎瘻造設のプロセスが簡略化され、手術時間が短縮され、合併症の発生率も低下しています。このような進歩により、PCNLはより安全であるだけでなく、複雑な腎解剖学的構造、単腎、複数の合併症を持つ患者など、より幅広い患者像に適応できるようになり、現代の泌尿器科診療における有用性が拡大しています。

なぜPCNLは、さまざまな患者層で好まれる治療法となりつつあるのでしょうか？

経皮的腎結石除去術の採用はさまざまな患者層で着実に増加しており、これは複雑な結石症に対するその汎用性と有効性を反映しています。成人集団では、PCNLは大きな結石や複数の結石を管理するための第一選択となりつつあり、また非侵襲的な方法が失敗した場合の第一選択にもなっています。PCNLは結石除去の成功率が高く、再発率も比較的低いため、結石症に対する確実な解決策を求める患者にとって魅力的な選択肢となっています。小児泌尿器科は、小型化された器具とより低リスクの手技の開発により、PCNLが普及しつつあるもう一つの分野です。小児では、PCNLは、そうでなければ複数の処置を必要とする症候性結石の治療に安全な選択肢を提供します。複数の合併症を持つことが多い高齢の患者も、開腹手術に比べて合併症の発生率が低いPCNLの低侵襲性から利益を得ています。さらに、馬蹄腎や孤発腎の患者など、解剖学的にユニークな課題を持つ患者がPCNLを受けることが増えているのは、この手技の適応性の高さと、外科医が特殊な装置を用いてアプローチを調整する能力のためです。PCNLの適用範囲は肥満患者にもさらに広がっており、経皮的アプローチはより侵襲的な選択肢よりも明らかに有利で、手術の負担と回復時間を軽減します。このように多様な患者集団にPCNLが広く受け入れられていることは、この手技の多様性の証であるだけでなく、さまざまな患者集団の特定のニーズを満たすためにPCNL手技をカスタマイズする泌尿器科医の専門性が高まっていることの証でもあります。

経皮的腎結石除去術市場の成長を後押ししているのは？

経皮的腎結石除去術市場の成長は、技術の進歩、腎臓結石症の罹患率の上昇、低侵襲オプションに対する患者や臨床医の意識の高まりなど、いくつかの要因によってもたらされます。主な成長要因の1つは腎結石症の世界の有病率の上昇であり、これは食習慣、肥満、代謝異常などの生活習慣要因と密接な関係があります。腎結石症が年齢層を超えて一般的になっているため、PCNLのような効果的な外科治療に対する需要が高まっています。さらに、手術機器や画像診断装置の技術革新により、PCNLの安全性と精度が向上しており、複雑な解剖学的構造や高リスクのプロファイルを持つ患者を含め、より幅広い患者にとって実行可能な選択肢となっています。小型化された器具が利用できるようになったことで、従来のPCNLでは侵襲的すぎると判断されていた小児や老人医療を中心に、PCNLの患者層が広がっています。もう1つの重要な要因は、患者やヘルスケア提供者の間で、回復時間の短縮、合併症の減少、美容的結果の向上につながる低侵襲手術に対する嗜好が高まっていることです。泌尿器科専門センターの増加や、高度なPCNL技術の訓練を受けた熟練外科医の存在も市場拡大に寄与しています。さらに、新しいPCNL機器の規制当局による承認や、専門的な外科治療へのアクセスを改善することを目的とした支持的なヘルスケア政策が、より広範な普及を促しています。ロボットシステムとコンピュータ支援ナビゲーションの統合は、精度の向上と手技習得曲線の短縮を約束する技術であるため、市場をさらに推進する構えです。効果的で低侵襲な腎結石治療への需要が高まり続ける中、これらの要因が総合的にPCNL市場の軌道を形成し、同市場を力強い成長へと位置づけています。

調査対象企業の例（全42件）

  • Boston Scientific Corporation
  • Cook Medical
  • Electro Medical Systems SA
  • innoMedicus AG
  • Karl Storz Se & Co. KG
  • Olympus Corporation
  • PolyDiagnost

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17592

Global Percutaneous Nephrolithotomy Market to Reach US$445.2 Million by 2030

The global market for Percutaneous Nephrolithotomy estimated at US$328.4 Million in the year 2023, is expected to reach US$445.2 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$87.7 Million While China is Forecast to Grow at 6.6% CAGR

The Percutaneous Nephrolithotomy market in the U.S. is estimated at US$87.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$93.6 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Percutaneous Nephrolithotomy Market - Key Trends and Drivers Summarized

What Is Percutaneous Nephrolithotomy and Why Is It the Preferred Treatment for Large Kidney Stones?

Percutaneous Nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove large or complex kidney stones that cannot be effectively treated through less invasive techniques such as extracorporeal shock wave lithotripsy (ESWL) or ureteroscopy. But what makes PCNL distinct and why is it the go-to choice for large renal calculi? The procedure involves making a small incision, usually less than one centimeter, in the patient’s back through which a nephroscope—a specialized surgical instrument—is inserted directly into the kidney. This allows the surgeon to visualize the stones and use instruments to break them into smaller pieces for removal. A tube is often placed temporarily to ensure proper drainage and healing post-procedure. PCNL is particularly effective for stones larger than 2 cm in diameter, staghorn stones, or when stones are located in challenging anatomical locations within the kidney. The technique is highly efficient, with a stone clearance rate exceeding 90% in most cases, making it the preferred option for treating large or multiple stones in a single setting. Compared to open surgery, PCNL is associated with less postoperative pain, shorter hospital stays, and quicker recovery times, providing a significant advantage to patients who need a definitive solution to complex kidney stones.

How Have Recent Technological Advances Enhanced the Safety and Efficacy of PCNL?

The field of Percutaneous Nephrolithotomy has benefited immensely from technological advancements that have significantly improved the safety profile, precision, and outcomes of the procedure. One of the most noteworthy developments is the miniaturization of surgical instruments, leading to what is known as mini-PCNL or ultra-mini-PCNL, which uses even smaller nephroscopes and access tracts. This technique reduces the risk of bleeding and minimizes trauma to the kidney, making it suitable for pediatric patients and adults alike. Another pivotal innovation is the use of advanced imaging modalities, such as fluoroscopy, ultrasound, and real-time CT guidance, which allow for more precise stone targeting and safer access to the kidney, even in anatomically complex cases. Furthermore, new lithotripters, including laser and pneumatic devices, provide enhanced power for fragmenting hard stones, thus reducing the need for repeat procedures. These energy sources have improved efficiency, allowing surgeons to break down larger stones more quickly while preserving healthy tissue. The integration of robotics and computer-assisted navigation in PCNL is also on the horizon, promising to further increase accuracy and reduce the learning curve for urologists. Additionally, single-step dilation techniques and balloon dilators have simplified the process of creating the nephrostomy tract, decreasing operative time and lowering the incidence of complications. With these advancements, PCNL has become not only safer but also more adaptable to a wider range of patient profiles, including those with complex renal anatomy, solitary kidneys, or multiple co-morbidities, thereby expanding its utility in modern urological practice.

Why Is PCNL Becoming the Preferred Treatment Option Across Different Patient Demographics?

The adoption of Percutaneous Nephrolithotomy is steadily increasing across various patient demographics, reflecting its versatility and efficacy in addressing complex stone disease. In adult populations, PCNL is becoming the first-line option for managing large or multiple stones, as well as for cases where non-invasive methods have failed. The procedure’s high success rate in clearing stones, combined with its relatively low recurrence rate, makes it an attractive choice for patients seeking a definitive solution to their condition. Pediatric urology is another area where PCNL is gaining traction, thanks to the development of miniaturized instruments and lower-risk techniques. In children, PCNL offers a safe alternative for treating symptomatic stones that would otherwise require multiple procedures. Elderly patients, who often present with multiple comorbid conditions, also benefit from PCNL’s minimally invasive nature, which results in a lower overall complication rate compared to open surgery. Moreover, individuals with unique anatomical challenges, such as horseshoe kidneys or patients with a solitary kidney, are increasingly undergoing PCNL due to the procedure’s adaptability and the surgeon’s ability to tailor the approach using specialized equipment. The application of PCNL is further expanding to include obese patients, where the percutaneous approach offers a clear advantage over more invasive options, reducing surgical stress and recovery time. This broadening acceptance of PCNL across diverse patient groups is not just a testament to the procedure’s versatility but also to the growing expertise of urologists in customizing PCNL techniques to meet the specific needs of different patient populations.

What’s Fueling the Growth of the Percutaneous Nephrolithotomy Market?

The growth in the Percutaneous Nephrolithotomy market is driven by several factors, including technological advancements, the rising incidence of kidney stone disease, and increasing patient and clinician awareness of minimally invasive options. One of the primary growth drivers is the global rise in the prevalence of nephrolithiasis, which is closely linked to lifestyle factors such as dietary habits, obesity, and metabolic disorders. With kidney stone disease becoming more common across age groups, there is a growing demand for effective surgical treatments like PCNL. Additionally, technological innovations in surgical equipment and imaging modalities are enhancing the safety and precision of PCNL, making it a more viable option for a broader range of patients, including those with complex anatomy or high-risk profiles. The availability of miniaturized instruments has expanded the patient base for PCNL, particularly in pediatric and geriatric care, where traditional PCNL might have been deemed too invasive. Another key factor is the increasing preference among patients and healthcare providers for minimally invasive procedures, which are associated with shorter recovery times, fewer complications, and better cosmetic outcomes. The growth of specialized urology centers and the presence of skilled surgeons who are trained in advanced PCNL techniques are also contributing to market expansion. Moreover, regulatory approval of new PCNL devices and supportive healthcare policies aimed at improving access to specialized surgical care are encouraging more widespread adoption. The integration of robotic systems and computer-assisted navigation is poised to further propel the market, as these technologies promise to enhance precision and reduce the procedural learning curve. Collectively, these factors are shaping the trajectory of the PCNL market, positioning it for robust growth as the demand for effective and minimally invasive kidney stone treatments continues to rise.

Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation
  • Cook Medical
  • Electro Medical Systems SA
  • innoMedicus AG
  • Karl Storz Se & Co. KG
  • Olympus Corporation
  • PolyDiagnost

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Percutaneous Nephrolithotomy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Kidney Stones Globally Spurs Demand for Minimally Invasive Surgical Techniques
    • Advancements in Imaging Technologies Strengthen the Business Case for PCNL in Complex Stone Management
    • Rising Adoption of Miniaturized Instruments Expands Addressable Market Opportunity in Pediatric and Geriatric Segments
    • Integration of Robotics and Computer-Assisted Navigation Propels Market Growth in High-Precision Stone Removal
    • Improved Post-Operative Outcomes and Reduced Recovery Times Sustain Growth of PCNL in High-Risk Patient Groups
    • Surge in Health Awareness and Early Diagnosis Accelerates Demand for Surgical Stone Management Solutions
    • Technological Innovations in Lithotripters and Energy Sources Strengthen PCNL's Position in the Kidney Stone Treatment Spectrum
    • Rising Geriatric Population and Associated Urological Disorders Expand the Addressable Market for PCNL
    • Increasing Medical Tourism in Emerging Markets Generates New Opportunities for PCNL Procedures
    • High Incidence of Lifestyle-Related Risk Factors for Nephrolithiasis Creates Sustained Demand for Surgical Interventions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Percutaneous Nephrolithotomy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CHINA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • INDIA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • LATIN AMERICA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MIDDLE EAST
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • AFRICA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION